fluorobenzenes has been researched along with Cardiac Remodeling, Ventricular in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 13 (61.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capoulade, R; Chan, KL; Clavel, MA; Côté, N; Després, JP; Dumesnil, JG; Mathieu, P; Pibarot, P; Tam, JW; Teo, KK | 1 |
| Balligand, JL; Beauloye, C; Hamelet, J; Herijgers, P; Hermida, N; Hilfiker-Kleiner, D; Horman, S; Markl, A; Noppe, G; Van Assche, T; van Bilsen, M; Vanderper, A | 1 |
| Aakhus, S; Andreassen, J; Askevold, ET; Aukrust, P; Broch, K; Gjertsen, E; Godang, K; Gullestad, L; Smith, HJ; Stueflotten, W; Svendsmark, R; Ueland, T; Yndestad, A | 1 |
| Cao, G; Llambí, HG; Milei, J; Muller, A; Ottaviano, G | 1 |
| Fu, M; Hu, SJ; Mou, Y; Yang, Y | 1 |
| Brown, L; Chan, V; Hoey, A; Loch, D | 1 |
| Baraka, A; El Ghotny, S; Guemei, A; Mikhail, M | 1 |
| Ashton, E; Krum, H; Reid, C; Rosenfeldt, F; Schneider, H; Skiba, M; Tonkin, A; Windebank, E | 1 |
| Adams, V; Beck, EB; Erbs, S; Gielen, S; Hambrecht, R; Höllriegel, R; Kränkel, N; Linke, A; Möbius-Winkler, S; Schuler, G; Thiele, H | 1 |
| Yalta, K | 1 |
| Chen, Y; Cheng, X; Ding, Y; Fu, M; Liao, M; Liao, Y; Tang, T; Xiao, H; Xie, J; Xu, Y; Yao, R; Yu, X; Zhao, G | 1 |
| Aragoncillo, P; Caro-Vadillo, A; Fernández-Cruz, A; Gómez-Garre, D; González-Rubio, ML; Muñoz-Pacheco, P | 1 |
| Bugan, B; Celik, T | 1 |
| Du, QJ; Ge, JB; Gong, H; Hu, K; Li, H; Qiu, ZH; Sun, AJ; Wu, CN; Zhang, WB; Zhao, G; Zou, YZ | 1 |
| Ge, J; Hu, X; Huang, Z; Jia, J; Sun, A; Xie, X; Yao, R | 1 |
| Chello, M; Spadaccio, C | 1 |
| Brown, L; Hoey, A; Levick, S; Loch, D | 1 |
| Bleske, BE; Boluyt, MO; Cirrincione, GM; Hwang, HS | 1 |
| Cooper, SA; Ferrario, C; Habibi, J; Hayden, MR; Muniyappa, R; Qazi, MA; Sowers, JR; Stump, C; Thyfault, J; Tramontano, A; Whaley-Connell, A | 1 |
| Amarena, J; Ashton, E; Kalff, V; Krum, H; Reid, C; Rogers, J; Singh, B; Tonkin, A | 1 |
| Goldstein, S; Imai, M; Jiang, A; Rastogi, S; Sabbah, HN; Sharov, VG; Wang, M; Zacà, V | 1 |
5 trial(s) available for fluorobenzenes and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Canada; Chi-Square Distribution; Disease Progression; Female; Fluorobenzenes; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Insulin Resistance; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2013 |
The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cholesterol, LDL; Extracellular Matrix; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.
Topics: Chronic Disease; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2011 |
High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study.
Topics: Administration, Oral; Aged; Cells, Cultured; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Female; Fluorobenzenes; Heart Failure; Humans; Male; Middle Aged; Neovascularization, Physiologic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2011 |
Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
Topics: Adult; Aged; Chronic Disease; Cytokines; Double-Blind Method; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neurotransmitter Agents; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Systole; Ventricular Remodeling | 2007 |
16 other study(ies) available for fluorobenzenes and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
Topics: Actins; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Collagen Type I; Diastole; Disease Models, Animal; Enzyme Activation; Fibroblasts; Fibrosis; Fluorobenzenes; Heart Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leptin; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Procollagen; Pyrimidines; Rats; Receptors, LDL; Recovery of Function; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Time Factors; Transfection; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Rosuvastatin increases myocardial microvessels in SHR rats. Role of thioredoxin-1 and peroxiredoxin-2 expression.
Topics: Animals; Fluorobenzenes; Heart; Male; Microvessels; Peroxiredoxins; Pyrimidines; Rats; Rats, Inbred SHR; Rosuvastatin Calcium; Sulfonamides; Thioredoxins; Ventricular Remodeling | 2014 |
Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins.
Topics: Animals; Calcium-Binding Proteins; Disease Models, Animal; Fluorobenzenes; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-10; Interleukin-6; Male; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sulfonamides; Ventricular Remodeling | 2009 |
Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.
Topics: Aging; Animals; Blood Pressure; Diastole; Disease Models, Animal; Echocardiography; Fluorobenzenes; Heart; Heart Failure; Hypertension; Lipoproteins, LDL; Male; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Systole; Ventricular Remodeling | 2009 |
Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats.
Topics: Animals; Blood Pressure; Caspase 3; Drug Delivery Systems; Fluorobenzenes; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Male; Myocardium; NG-Nitroarginine Methyl Ester; p38 Mitogen-Activated Protein Kinases; Papillary Muscles; Pyrimidines; Random Allocation; Rats; Rosuvastatin Calcium; Sulfonamides; Tretinoin; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2009 |
Insulin resistance due to statin therapy: a potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure?
Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2011 |
Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
Topics: Animals; Blood Pressure; Blotting, Western; Cholesterol; Echocardiography; Fluorobenzenes; Heart; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Lipoproteins, LDL; Male; Myocardial Infarction; Myocardium; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Triglycerides; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2010 |
Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.
Topics: Animals; Blood Pressure; Disease Models, Animal; Echocardiography, Doppler, Color; Fluorobenzenes; Follow-Up Studies; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pilot Projects; Pyrimidines; Rats; Rats, Inbred SHR; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Treatment Outcome; Ventricular Remodeling | 2010 |
Unending debate: statin dilemma in the management of heart failure.
Topics: Endothelium, Vascular; Female; Fluorobenzenes; Heart Failure; Humans; Male; Neovascularization, Physiologic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2011 |
The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; Caspase 3; Fibrosis; Fluorobenzenes; Forkhead Transcription Factors; Hypertension; Hypertrophy; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Nerve Tissue Proteins; Protein Kinase C; Protein Kinase C beta; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Survivin; Ventricular Remodeling | 2012 |
Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats.
Topics: Animals; Cytokines; Fluorobenzenes; Gene Expression Regulation; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Ischemia; Pyrimidines; Random Allocation; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2013 |
Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure.
Topics: Animals; Disease Models, Animal; Dogs; Fluorobenzenes; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2013 |
Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Desoxycorticosterone; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy; Male; Myocardium; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sodium Chloride, Dietary; Sulfonamides; Ventricular Remodeling | 2006 |
3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Blotting, Western; Body Weight; Cardiomegaly; Collagen; Constriction, Pathologic; DNA Probes; Extracellular Matrix; Fibronectins; Fluorobenzenes; Gene Expression; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Remodeling | 2006 |
Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
Topics: Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Female; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Glycoproteins; Mice; Myocardium; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Pyrimidines; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Renin; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2007 |
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.
Topics: Animals; Coronary Angiography; Dogs; Fluorobenzenes; Heart Failure; Hematopoietic Stem Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Myocardium; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |